These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 20219430)

  • 21. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
    Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
    Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A "freeze-all" embryo strategy after in vitro maturation: a novel approach in women with polycystic ovary syndrome?
    Ortega-Hrepich C; Stoop D; Guzmán L; Van Landuyt L; Tournaye H; Smitz J; De Vos M
    Fertil Steril; 2013 Oct; 100(4):1002-7. PubMed ID: 23850301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The study of the efficiency of in vitro maturation of ovarian tissue oocytes in pediatric patients.
    Ito K; Takae S; Nakamura K; Furuyama S; Nakajima M; Suzuki Y; Iwahata H; Sugishita Y; Horage Y; Suzuki N
    J Assist Reprod Genet; 2023 Dec; 40(12):2787-2797. PubMed ID: 37779181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation.
    Huang JY; Tulandi T; Holzer H; Tan SL; Chian RC
    Fertil Steril; 2008 Mar; 89(3):567-72. PubMed ID: 17543957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation.
    Oktay K; Demirtas E; Son WY; Lostritto K; Chian RC; Tan SL
    Fertil Steril; 2008 Jan; 89(1):228.e19-22. PubMed ID: 17517403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrieval of immature oocytes from unstimulated ovaries followed by in vitro maturation and vitrification: A novel strategy of fertility preservation for breast cancer patients.
    Huang JY; Chian RC; Gilbert L; Fleiszer D; Holzer H; Dermitas E; Elizur SE; Gidoni Y; Levin D; Son WY; Tan SL
    Am J Surg; 2010 Jul; 200(1):177-83. PubMed ID: 20637351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncofertility case report: live birth 10 years after oocyte in vitro maturation and zygote cryopreservation.
    Rodrigues P; Marques M; Pimentel S; Rato M; Carvalho P; Correia SC; Mendes N; Amaral H; Fernandes JP; Carvalho MJ; Plancha CE
    J Assist Reprod Genet; 2020 Dec; 37(12):3089-3094. PubMed ID: 33113072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cryopreservation of in vitro matured oocytes after ex vivo oocyte retrieval from gynecologic cancer patients undergoing radical surgery.
    Park CW; Lee SH; Yang KM; Lee IH; Lim KT; Lee KH; Kim TJ
    Clin Exp Reprod Med; 2016 Jun; 43(2):119-25. PubMed ID: 27358831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro maturation of human immature oocytes for fertility preservation.
    Chian RC; Uzelac PS; Nargund G
    Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian reserve and response to IVF and in vitro maturation treatment following chemotherapy.
    Das M; Shehata F; Son WY; Tulandi T; Holzer H
    Hum Reprod; 2012 Aug; 27(8):2509-14. PubMed ID: 22617122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient.
    Prasath EB; Chan ML; Wong WH; Lim CJ; Tharmalingam MD; Hendricks M; Loh SF; Chia YN
    Hum Reprod; 2014 Feb; 29(2):276-8. PubMed ID: 24327539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation.
    Pereira N; Kelly AG; Stone LD; Witzke JD; Lekovich JP; Elias RT; Schattman GL; Rosenwaks Z
    Fertil Steril; 2017 Sep; 108(3):532-538. PubMed ID: 28865552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience.
    Mayeur A; Puy V; Windal V; Hesters L; Gallot V; Benoit A; Grynberg M; Sonigo C; Frydman N
    J Assist Reprod Genet; 2021 Jul; 38(7):1767-1775. PubMed ID: 33797007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of letrozole administration on oocyte morphology in breast cancer patients undergoing fertility preservation.
    Bercaire LMN; Cavagna M; Donadio NF; Rocha AR; Portela R; Alves VR; Santos TBB; Cavagna F; Dzik A; Gebrim LH; Nahas EAP
    JBRA Assist Reprod; 2020 Jul; 24(3):257-264. PubMed ID: 32293820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IVF versus ICSI for the fertilization of in-vitro matured human oocytes.
    Walls M; Junk S; Ryan JP; Hart R
    Reprod Biomed Online; 2012 Dec; 25(6):603-7. PubMed ID: 23063820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
    Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
    Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
    Quinn MM; Cakmak H; Letourneau JM; Cedars MI; Rosen MP
    Hum Reprod; 2017 Mar; 32(3):568-574. PubMed ID: 28122888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes.
    Chian RC; Huang JY; Gilbert L; Son WY; Holzer H; Cui SJ; Buckett WM; Tulandi T; Tan SL
    Fertil Steril; 2009 Jun; 91(6):2391-8. PubMed ID: 18579139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of ovarian stimulation response in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins to patients undergoing ovarian stimulation with gonadotropins alone for elective cryopreservation of oocytes†.
    Pereira N; Hancock K; Cordeiro CN; Lekovich JP; Schattman GL; Rosenwaks Z
    Gynecol Endocrinol; 2016 Oct; 32(10):823-826. PubMed ID: 27114051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immature Oocyte for Fertility Preservation.
    Son WY; Henderson S; Cohen Y; Dahan M; Buckett W
    Front Endocrinol (Lausanne); 2019; 10():464. PubMed ID: 31379739
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.